skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Refined by: Journal Title: The Bmj remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Flawed evidence underpins approval of new cancer drugs
Material Type:
Article
Add to My Research

Flawed evidence underpins approval of new cancer drugs

BMJ (Online), 2019-09, Vol.366, p.l5399-l5399 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go tohttp://group.bmj.com/group/rights-licensing/permissions2019BMJ ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.l5399 ;PMID: 32027600

Full text available

2
Communicating emerging risks of SGLT2 inhibitors—timeliness and transparency of medicine regulators
Material Type:
Article
Add to My Research

Communicating emerging risks of SGLT2 inhibitors—timeliness and transparency of medicine regulators

BMJ (Online), 2020-04, Vol.369, p.m1107-m1107 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go tohttp://group.bmj.com/group/rights-licensing/permissions2020BMJ ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.m1107 ;PMID: 32349976

Full text available

3
“Asset exchange”—interactions between patient groups and pharmaceutical industry: Australian qualitative study
Material Type:
Article
Add to My Research

“Asset exchange”—interactions between patient groups and pharmaceutical industry: Australian qualitative study

BMJ (Online), 2019-12, Vol.367, p.l6694-l6694 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2019 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.l6694 ;PMID: 31831471

Full text available

4
Pathways to independence: towards producing and using trustworthy evidence
Material Type:
Article
Add to My Research

Pathways to independence: towards producing and using trustworthy evidence

BMJ (Online), 2019-12, Vol.367, p.l6576-l6576 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go tohttp://group.bmj.com/group/rights-licensing/permissions2019BMJ ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.l6576 ;PMID: 31796508

Full text available

5
Industry funding of patient and health consumer organisations: systematic review with meta-analysis
Material Type:
Article
Add to My Research

Industry funding of patient and health consumer organisations: systematic review with meta-analysis

BMJ (Online), 2020-01, Vol.368, p.l6925-l6925 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2020 BMJ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2020 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.l6925 ;PMID: 31969320

Full text available

6
UK deal over inclisiran
Material Type:
Article
Add to My Research

UK deal over inclisiran

BMJ (Online), 2020-02, Vol.368, p.m579-m579 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go tohttp://group.bmj.com/group/rights-licensing/permissions2020BMJ ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.m579 ;PMID: 32071100

Full text available

7
Overdiagnosis of bone fragility in the quest to prevent hip fracture
Material Type:
Article
Add to My Research

Overdiagnosis of bone fragility in the quest to prevent hip fracture

BMJ (Online), 2015-05, Vol.350 (may26 12), p.h2088-h2088 [Peer Reviewed Journal]

BMJ Publishing Group Ltd 2015 ;Copyright BMJ Publishing Group LTD May 26, 2015 ;ISSN: 0959-8138 ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.h2088 ;PMID: 26013536

Full text available

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To

Searching Remote Databases, Please Wait